small-logo
ProfessionalsCapabilitiesInsights & NewsCareersLocations
About UsAlumniOpportunity & InclusionPro BonoCorporate Social Responsibility
Stay Connected:
facebookinstagramlinkedintwitteryoutube
Site Search
  • Professionals (170)
  • Capabilities (33)
  • Experience (16)
  • Insights & News (610)
  • Other Results (26)

Professionals 170 results

Nimalka Wickramasekera
Nimalka Wickramasekera
Partner
  • Los Angeles, 
  • Silicon Valley
Email
+1 213-615-1819
vCard

Partner

  • Los Angeles
  • Silicon Valley
T. Reed Stephens
T. Reed Stephens
Partner
  • Washington, DC
Email
+1 202-282-5795
vCard

Partner

  • Washington, DC
Charles B. Klein
Charles B. Klein
Partner
  • Washington, DC
Email
+1 202-282-5977
vCard

Partner

  • Washington, DC
View All Professionals

Capabilities 33 results

Industry

Medical Devices

The medical device industry is currently undergoing monumental change—from supply chain challenges to disruptive technologies and economic fluctuations. To pave the way for a more accessible and innovative health care landscape—including advances in wearables, implants, diagnostics, mobility, drug delivery—the evolving and expansive medical device industry faces wide-ranging legal needs. Clients in this sector can tap the remarkable depth and breadth of our sector-focused and skilled attorneys in the U.S. and abroad. Our Health Care & Life Sciences Industry Group engages clients at all points in the product development life cycle to provide sound advice and practical solutions regardless of the client’s size or the complexity of their need. We help clients navigate today’s complex regulatory landscape, defend products and reputations in the face of high-profile product liability and mass tort claims, protect innovative intellectual property (IP), and leverage cross-border experience to advise on commercial transactions....Read more

Industry

Life Sciences

Winston has been a major player in the life sciences industry for decades. We represent market-leading clients across this broad sector, including companies involved in pharmaceuticals, biologics, biosimilars, biotechnology, and medical devices. Our attorneys are seasoned practitioners—many of whom have technical degrees in areas key to the life sciences sector, including biology, chemistry, pharmacy, and biomedical engineering—and bring a unique understanding of the industry and perspective to our representations....Read more

Practice Area

Trade Secrets, Non Competes & Restrictive Covenants

Theft of trade secrets and other confidential information occurs all too frequently in today’s global, highly mobile, and competitive marketplace. In the course of advising clients, we have developed comprehensive, yet scalable, strategies for both mitigating against and responding to issues along the trade secrets protection spectrum, including helping position clients proactively before trade secrets theft occurs....Read more

Experience 16 results

Experience

|

April 1, 2025

PDI Technologies Acquisition of P97 Networks

Experience

|

November 25, 2024

Creative Global Technologies Closes On Initial Public Offering

Experience

|

November 11, 2024

Court Square Capital Partners in its Definitive Agreement to Sell Advanced Diabetes Supply Group for US$1.1B

View All Experience

Insights & News 610 results

Client Alert

|

June 13, 2025

|

2 Min Read

Federal Circuit Reverses US$200M+ Jury Verdicts Because Asserted Claims Are Unpatentable Under § 101

According to 35 U.S.C. § 101, “any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof” may be patentable. Courts and litigants often struggle in determining what falls outside this scope—i.e., what is unpatentable subject matter. The Federal Circuit Court of Appeals dealt with this issue in a series of appeals between USAA v. PNC Bank (CAFC Nos. 2023-1639, 2023-1778, 2023-1866, 2025-1276, 2025-1277, and 2025-1341), held that the claims in the patents at issue recite unpatentable subject matter, and reversed the entries of judgment for the US$218M and US$4.3M jury verdicts that issued out of the Eastern District of Texas.

Client Alert

|

June 10, 2025

|

3 Min Read

PTAB Acting Director Denies IPR Merely Because Petitioner Knew of the Challenged Patent Over a Decade Ago

We previously reported how the PTAB’s institution rate has fallen to approximately 40% in the new administration, with many of those denials stemming from the PTAB’s increased usage of its discretionary denial processes to deny IPR challenges without otherwise addressing the merits of the identified prior art. The latest grant of discretionary denial continues that trend and exemplifies the current challenges in pursuing IPR/PGR invalidity challenges at the U.S. Patent Office. 

Client Alert

|

May 20, 2025

|

2 Min Read

ITC Clarifies Scope of the Economic Prong of the Domestic Industry Requirement, Allowing Investments That Predate the Asserted Patent Issue Date

In an unusual order recently issued by the U.S. International Trade Commission (ITC), the ITC vacated an ALJ’s Final Initial Determination (ID) on sub-prongs (A) and (B) of the economic prong of the domestic industry requirement, finding error in his decision to exclude investments made prior to issuance of the asserted patents. In Certain Oil Vaporizing Devices, Components Thereof, and Products Containing the Same, the ALJ had found infringement, validity, and satisfaction of the technical prong, but he recommended no exclusion order solely because certain of the complainant’s investments under sub-prongs (A) and (B) were incurred prior to the issue date of the asserted patents. See Inv. No. 337-TA-1392, Comm’n Order at 2 (May 16, 2025). That decision broke from over a decade of precedent, the ITC’s order explained.

View All Insights & News

Other Results 26 results

Law Glossary

What Is Internet of Things (IoT) Law?

The Internet of Things (IoT) area of the law relates to internet-connected devices, from smartphones to thermostats, which may collect user data and conduct analytics. In 2015, the Federal Trade Commission (FTC) issued guidelines on best practices and recommendations for companies providing home, wearable, and other personal connected devices. The FTC has recommended industry self-regulation as well as minimal collection and retention of consumer data in relation to IoT devices. The Commission also encourages companies to offer consumers data usage options and data sharing notifications....Read more

Law Glossary

What Is the FDA?

The FDA stands for the Food and Drug Administration. It is a federal agency charged with protecting the public by regulating the safety and security of drugs, biological products, veterinary medications, and medical devices. FDA responsibilities also cover the safety of: foods for U.S. consumers, cosmetics, animal feed, and radiation-emitting products. Various rules may be established and enforced by the agency in response to U.S. laws or presidential executive orders....Read more

Law Glossary

What Is Tracking and Monitoring Law?

Tracking and monitoring law is related to the rights of individuals and often addressed through state legislation. Tracking law looks at when and how individuals can be tracked through GPS devices and location services. Employers have the right to track company vehicles through GPS devices but cannot track an employee’s vehicle in many states without employee consent. (A written policy on tracking and monitoring may be required, with the policies stating a business purpose for the activities.) Tracking apps on mobile phones can continue to broadcast an employee’s location even after work hours. That is why companies must ensure they are satisfying employees’ expectations of privacy....Read more
Logo
facebookinstagramlinkedintwitteryoutube

Copyright © 2025. Winston & Strawn LLP

AlumniCorporate Transparency Act Task ForceDEI Compliance Task ForceEqual Rights AmendmentLaw GlossaryThe Oval UpdateWinston MinutePrivacy PolicyCookie PolicyFraud & Scam AlertsNoticesSubscribeAttorney Advertising